Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel-Reference-Cited by-同舟云学术

Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel

Published:2018-12 Issue:6 Volume:18 Page:e1323-e1337
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Marschner Norbert,Salat Christoph,Söling Ulrike,Hansen Richard,Grebhardt Sina,Harde Johanna,Nusch Arnd,Potthoff Karin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2);Cardoso;Ann Surg Oncol,2014

2. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil–based paclitaxel in women with breast cancer;Gradishar;J Clin Oncol,2005

3. Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer;Ibrahim;J Clin Oncol,2005

4. Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer;Gradishar;J Clin Oncol,2009

5. Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity;International Journal of Molecular Sciences;2022-12-09

2. Nanoparticle Albumin-Bound-Paclitaxel Instead of Standard Paclitaxel in Adjuvant Chemotherapy Regimen for Breast Cancer Under COVID-19 Pandemic—A Single Center Feasibility Study in China;Science of Advanced Materials;2022-02-01

3. Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives;Therapies;2021-11

4. A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer;Cancer Research and Treatment;2021-08-13

5. A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer;BMC Cancer;2021-07-18